A high-performance diagnostic device designed for rapid and precise measurement of glycosylated hemoglobin (HbA1c), the gold standard for diabetes diagnosis. It supports standard mode and variant mode, providing results within 60-90 seconds with high efficiency and reliable results.
Manufactured by
Guangzhou, Guangdong, China
Guangzhou Wondfo Biotech Co., Ltd. founded in 1992 and headquartered in Guangzhou science city. Wondfo focuses on the R D, manufacturing, sales and service of IVD industry , providing professional rapid diagnosis and chronic disease management solutions. Wondfo has 9 technology platforms . Our rapid diagnostic devices and reagents span a wide spectrum, including cardiovascular diseases, diabetes, renal functions, respiratory issues, fertility, DOA, infections, tumors, etc . We provide services to over 150 countries and regions . In 2015, Wondfo was listed on the Shenzhen Stock Exchange, becoming the first public company in POCT in China .
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
2 of 2 closest product alternatives
Danaher · United States
Point-of-care device for rapid blood glucose measurement in clinical settings. Analyzer provides immediate results for diabetes and metabolic assessment.
Citest Diagnostics Inc. · Canada
A hemoglobin measurement device designed to provide rapid quantitative results for hemoglobin analysis in blood samples.
© 2026 Suplivia · Home · Browse Products